Business Description
Zhaoke Ophthalmology Ltd
ISIN : KYG989M51017
Total Employee Number:
276Compare
Compare
Traded in other countries / regions
06622.Hong Kong9FX.Germany IPO Date
2021-04-29Description
Zhaoke Ophthalmology Ltd is an ophthalmic pharmaceutical company dedicated to the research, development, manufacture and commercialization of therapies that address unmet medical needs. The company has three flagship drug assets progressing towards potential market approval: NVK002 for myopia, CsA Ophthalmic Gel for DED and TAB014 for wAMD; and two drug assets in the clinical stage BRIMOCHOL PF for presbyopia and ZKY001 for corneal epithelial defects. Geographically the company operates in Hong Kong, Chinese Mainland, South Korea, and Others, of which it generates maximum revenue from Chinese Mainland.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.29 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | -1.47 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -0.61 | |||||
Beneish M-Score | 1.13 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 26.8 | |||||
3-Year EPS without NRI Growth Rate | 20.3 | |||||
3-Year FCF Growth Rate | 23 | |||||
3-Year Book Growth Rate | -13 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 49.84 | |||||
9-Day RSI | 49.72 | |||||
14-Day RSI | 49.28 | |||||
3-1 Month Momentum % | -3.95 | |||||
6-1 Month Momentum % | -23.58 | |||||
12-1 Month Momentum % | -33.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.18 | |||||
Quick Ratio | 4.14 | |||||
Cash Ratio | 2.93 | |||||
Days Inventory | 326.52 | |||||
Days Sales Outstanding | 75.26 | |||||
Days Payable | 17.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | -3.35 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 50.19 | |||||
Operating Margin % | -860.8 | |||||
Net Margin % | -653.14 | |||||
EBITDA Margin % | -624.73 | |||||
FCF Margin % | -828.17 | |||||
OCF Margin % | -813.08 | |||||
ROE % | -12.22 | |||||
ROA % | -10.13 | |||||
ROIC % | -28.18 | |||||
3-Year ROIIC % | 96.22 | |||||
ROC (Joel Greenblatt) % | -38.34 | |||||
ROCE % | -11.49 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 38.92 | |||||
PB Ratio | 0.8 | |||||
Price-to-Tangible-Book | 1.05 | |||||
EV-to-EBIT | -2.93 | |||||
EV-to-EBITDA | -2.93 | |||||
EV-to-Revenue | 18.31 | |||||
EV-to-FCF | -2.21 | |||||
Price-to-GF-Value | 0.97 | |||||
| Price-to-Net-Current-Asset-Value | 1.23 | |||||
| Price-to-Net-Cash | 2.09 | |||||
Earnings Yield (Greenblatt) % | -34.13 | |||||
FCF Yield % | -21.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhaoke Ophthalmology Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 35.139 | ||
| EPS (TTM) (HK$) | -0.418 | ||
| Beta | 0.8941 | ||
| 3-Year Sharpe Ratio | -0.06 | ||
| 3-Year Sortino Ratio | -0.1 | ||
| Volatility % | 38.84 | ||
| 14-Day RSI | 49.28 | ||
| 14-Day ATR (HK$) | 0.085231 | ||
| 20-Day SMA (HK$) | 2.53225 | ||
| 12-1 Month Momentum % | -33.97 | ||
| 52-Week Range (HK$) | 2.38 - 4.28 | ||
| Shares Outstanding (Mil) | 547.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhaoke Ophthalmology Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhaoke Ophthalmology Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zhaoke Ophthalmology Ltd Frequently Asked Questions
What is Zhaoke Ophthalmology Ltd(HKSE:06622)'s stock price today?
The current price of HKSE:06622 is HK$2.53. The 52 week high of HKSE:06622 is HK$4.28 and 52 week low is HK$2.38.
When is next earnings date of Zhaoke Ophthalmology Ltd(HKSE:06622)?
The next earnings date of Zhaoke Ophthalmology Ltd(HKSE:06622) is .
Does Zhaoke Ophthalmology Ltd(HKSE:06622) pay dividends? If so, how much?
Zhaoke Ophthalmology Ltd(HKSE:06622) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Zhaoke Ophthalmology Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers